Regeneron Pharmaceuticals Aktie
WKN: 881535 / ISIN: US75886F1075
06.06.2018 13:09:02
|
Regeneron, Zoetis Announce Research Collaboration - Quick Facts
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Zoetis Inc. (ZTS) announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments. Regeneron has granted Zoetis a license for its VelocImmune antibody technology, which Zoetis will use to develop monoclonal antibodies modified for species-specific use in companion and livestock animals.
Regeneron will receive a license fee, approval and sales milestone payments and royalties on any potential veterinary treatments.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Regeneron Pharmaceuticals Inc.mehr Nachrichten
Analysen zu Regeneron Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
Regeneron Pharmaceuticals Inc. | 527,00 | -1,09% |
|
Zoetis Inc (A) | 145,92 | -0,69% |
|